Incorrect Access Control in BMC Remedy Mid-Tier by BMC Software
CVE-2018-18862

8.8HIGH

Key Information:

Vendor

Bmc

Status
Remedy Mid-tier
Remedy Action Request System
Vendor
CVE Published:
21 March 2019

What is CVE-2018-18862?

BMC Remedy Mid-Tier versions 7.1.00 and 9.1.02.003 exhibit weaknesses in access control mechanisms within IT Asset Management forms. This vulnerability allows unauthorized users to access sensitive information through specific URLs, including those related to server connections and administration views. Proper configurations are essential to prevent exposure of critical data and ensure the security of the BMC Remedy AR System.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

References

http://packetstormsecurity.com/files/151021/BMC-Remedy-IT...
x_refsource_MISC
http://seclists.org/fulldisclosure/2019/Jan/11
x_refsource_MISC
https://docs.bmc.com/docs/ars91/en/release-notes-and-noti...
x_refsource_CONFIRM

CVSS V3.1

Score:
8.8
Severity:
HIGH
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.